32.jpg)
56.jpg)
Obesity treatment
Patent number:
P202130278
No items found.
The present invention shows the use of silibinin for the inhibition of pancreatic lipase, the enzyme responsible for the digestion of dietary fats. Such an effect supports the use of this compound for the prevention, improvement, alleviation and/or treatment of obesity and/or hyperlipidemia.
Countries:
Spain
Regions:
Andalusia
Region of Murcia
Centers:
UNIVERSIDAD DE GRANADA, UNIVERSIDAD CATOLICA SAN ANTONIO DE MURCIA
Other entities:
Sectors:
Health
Subsectors:
Pharmaceuticals
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
Treatment of obesity and hyperlipidemia. Secure administration. Lower risk of side effects. Low cost of raw material.
Comments